Many severe diseases, such as atherosclerosis, hypertension, Alzheimer's disease, diabetes, infertility etc are connected with an oxidative stress development and formation of reactive forms of oxygen in excess amounts, which include free radicals and peroxides. Formation of such substrates result in damage of many cell components, such as lipids, DNA and proteins [1] .
As a means of pathogenetic therapy of such diseases are frequently used an antioxidants. Despite rather large quantity of medicines with antioxidant properties, search of new compounds, which would meet safety and efficiency requirements is still relevant.
Previously it has been shown [2] that three derivatives of 8-(4 1 -hydroxy-3Rb e n z y l i d e n a m i n o ) -6 -t e r t -b u t y l -8Н- [1, 2, 4] triazolo [4,3-в] [1, 2, 4] triazine-7-ones exhibit high antioxidant properties. As the comparison compounds well-known antioxidants ionol and ascorbic acid were selected [3, 4] .
The aim of the study -to synthesize new derivatives of 8-(4 1 -hydroxy-3Rbenzylidenamino)-6-tert-butyl-8Н- [1, 2, 4] triazolo [4,3-b] [1, 2, 4] triazine-7-ones and to evaluate their antioxidant properties in screening test in vitro as compared with ionol and ascorbic acid.
Materials and methods. Test compounds were synthesized in Taras Shevchenko National University of Kyiv (Figure) . Antioxidant activity was studied in department of medical chemistry of SI «Institute of Pharmacology and Toxicology NAMS of Ukraine».
4-Amino-6-tert-butyl-3-methylthio-4H- [1, 2, 4] triazinine-5-one 1 was obtained by alkylating 4-Amino-6-tert-butyl-3thio-4H- [1, 2, 4] triazinine-5-one with iodomethane in alkaline conditions using the method [5] . 4-Amino-6-tert-butyl-3-hydrazino-4H- [1, 2, 4] triazinine-5-one 2 was obtained by boiling of 3-methylthioderivative 1 with excess of hydrazinhydrate in propanol-2 by method [6] . 8-amino-6-tert-butyl-8Н- [1, 2, 4] triazolo[4,3-в][1,2,4]triazine-7-он 3 was obtained by boiling of compound 2 with ortho formic ether in ethanol. Substituted 8-benzylidenamino-derivatives 5-10 were synthesized by standard Schiff method of alkali obtainment [7] . 1 Н-NMR spectra were recorded on the Bruker VXR-360 (Germany), the working frequency of 360.191 MHz, in DMSO-d6 using tetramethyl silane (TMS) as an internal standard. Chemical shifts are reported in ppm units with use of the d scale. Purity control of novel compounds was conducted by thin-layer chromatography in the system chloroform -methanol 9:1.
Synthesis of 8-amino-6-tert-butyl-8Н- [1, 2, 4] tria zolo [4,3-b] [1, 2, 4] [ 1 , 2 , 4 ] triazolo [4,3-b] [1, 2, 4] [1, 2, 4] triazolo [4,3-b] [1, 2, 4] [1, 2, 4] triazolo [4,3-b] [1, 2, 4] triazin-7-оne 7 was obtained as compound 5 from 2.08 g (0.01 M) 8-amino-6-tertbutyl-8Н- [1, 2, 4] 
Synthesis of 6-tert-butyl-8-[(furan-2y l m e t h y l e n e ) -a m i n o ] -8 Н -

Synthesis of 6-tert-butyl-8-[(thiophen-2-ylmethylene)-amino]-8Н-
Synthesis of 6-tert-butyl-8-[(2-hydroxy naphthalen-1-ylmethylene)-amino]-8Н-
Scheme of synthesis of 8-(4 1 -hydroxy-3R-benzylidenamino)-6-tert-butyl-8Н- [1, 2, 4] triazolo [4,3-b] [1, 2, 4] Synthesis of 6-tert-butyl-8-[(2 1 -hydroxy-3 1 -methoxybenzylidene)-amino]-8Н- [1, 2, 4] triazolo [4,3-b] [1, 2, 4] triazin-7-оne 8 l was obtained as compound 5 from 2.08 g (0.01 M) 8-amino-6-tertbutyl-8Н- [1, 2, 4] [1, 2, 4] triazolo [4,3-b] [1, 2, 4] triazin-7-оne 8 n was obtained as compound 5 from 2.08 g (0.01 M) 8-amino-6-tertbutyl-8Н- [1, 2, 4] 
Synthesis of 6-tert-butyl-8-[(4 1 -hydrox y -3 1 -e t h o x y b e n z y l i d e n e ) -a m i n o ] -
8Н- [1, 2, 4] triazolo [4,3-b] [1, 2, 4] [1, 2, 4] triazolo [4,3-b] [1, 2, 4] triazin-7-оne 10 was obtained as compound 5 from 2.08 g (0.01 M) 8-amino-6-tertbutyl-8Н- [1, 2, 4] Screening of compound's antioxidant activity (AOA) was studied in vitro by their ability to inhibit lipoperoxide formation, induced by FeSO 4 in yolk lipoproteids emulsion. [8, 9] . Ascorbic acid and ionol were taken as comparison compounds. The test was conducted by the following method. Each of compounds as 10 μM/ml solution diluted in DMSO, 0,5 ml 0,7 % FeSO 4 3 ml potassium-phosphate buffer were added to yolk emulsion. After for 60 min at 37 °С incubation, solution was cooled and used for determination of lipid peroxidation products, which react with thiobarbituric acid (TBA-active products), particularly, malonic dialdehyde (MDA). For this, to solution, obtained after incubation, 2 ml of cooled 20 % trichloroacetic acid and 0,05 ml trilon B (50 mg/l) were added. After centrifugation, 2 ml 1 % of freshly prepared tiobarbituric acid was added to each supernatant and incubated for 35 min at 95 °С. After cooling, 4 ml of buthanol-1 was added, and optical density of buthanol extracts was measured, using KFK-2 photo colorimeter at wave length of 540 nanometers. Each determination was repeated three times.
Synthesis of 8-[(benzo[1,3]dioxol-5y l m e t h y l e n e ) -a m i n o ] -6 -t e r t -b u t y l -8Н-
AOA of test and control samples was evaluated by formula:
• 100 %, where AOA = D c -optical density at 540 nm of control sample (DMSO without test compound); D t -optical density at 540 nm of test sample (DMSO with test compound);
Results and discussion. According to the data obtained (table), it is possible to note certain dependences of the test substances structures with their antioxidant properties.
Thus, the introduction of electronwithdrawing substituents (F, Cl, Br and COOMe) into the benzene ring leads to decrease of an antioxidant properties as to the base molecule 6-tert-butyl-8-(benzyl idene amino)-8Н- [1, 2, 4] tri azolo[4,3-b][1,2,4]triazin-7-оne 8 а without substitutes.
Replacing the benzene ring with heterocyclic thiophene 6 and furan 5 residues results in very strong prooxidant properties. Thus, 6-tert-butyl-8-[(furan-2 -y l m e t h y l e n e ) -a m i n o ] -8 Н - [ 1 , 2 , 4 ] triazolo [4,3-b] [1, 2, 4] triazin-7-оne 5 has the highest value of prooxidant activity: -110.9 % in relation to ascorbic acid and -134.1 % in relation to ionol.
It has been shown that antioxidant properties of the molecule depend sig-nificantly on the position of the hydroxyl group in the benzene ring. Thus, the highest activity value in the 2-ОН (8 і), 3-ОН (8 k) i 4-ОН (9 p) series is registered for compound 6-tert-butyl-8-[(41hydroxybenzylidene)-amino]-8Н- [1, 2, 4] triazolo [4,3-b] [1, 2, 4] triazin-7-оne 9 p. The lowest is for the compound (8 k) with the presence of a hydroxyl group in the third position of the benzene ring. It should be noted that this pattern persists with the introduction into the ring of electron-donating OCH 3 Analysing their antioxidant properties, we can conclude that condensed derivatives with a hydroxyl group have a higher AOA than their corresponding benzene derivatives with values of 48.08 % and 35.90 % (7 and 8 i) respectively. For substances 7, 8 a antioxidant properties were observed at the level of ascorbic acid, and substances 8 l, 8 o showed higher results than ascorbic acid.
Thus, a new series of 8Н- [1, 2, 4 ] triazolo[4,3-в][1,2,4]triazin-7-ones derivatives has been proposed, which may form the basis for the creation of new antioxidants.
Conclusions
A series of new derivatives of
8Н- [1, 2, 4] triazolo [4,3- 8Н-[1,2,4]triazolo[4,3-в] [1,2,4 ]triazin-7-ones
